PFA
ONC

Peak Financial Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Peak Financial Advisors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.38M Buy
+4,836
New +$1.43M 0.57% 41

Other funds holding ONC

CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
WAS
WESPAC Advisors SoCal Pasadena, California $560M AUM 37.11% 1-Year Est. Return
CST
Charles Schwab Trust Henderson, Nevada $1.79B AUM 17.47% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
S
Steadtrust Allen, Texas $198M AUM 99.37% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
CSP
Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return
EWM
Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return

Peak Financial Advisors's ONC Position: Q2 2026 in Review

Peak Financial Advisors opened a new position in BeOne Medicines Ltd (ONC) in Q2 2026: 4,836 shares worth $1.38M. The stake represents 0.57% of the portfolio and ranks #41 among its holdings.

25 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Peak Financial Advisors held 4,836 shares of BeOne Medicines Ltd worth $1.38M as of Q2 2026.
  • BeOne Medicines Ltd was a new Peak Financial Advisors position in Q2 2026.
  • BeOne Medicines Ltd made up 0.57% of Peak Financial Advisors's portfolio in Q2 2026, its #41 holding.
  • 25 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Peak Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.